DELFI Diagnostics is developing next-generation, blood-based tests for cancer detection using advanced machine-learning methods and whole-genome sequencing data. The DELFI platform focuses on fragmentomics, analyzing cell-free DNA (cfDNA) fragments to identify cancer. Their first product, FirstLook Lung, is a laboratory-developed screening test for individuals eligible for lung cancer screening. The company values science, pragmatism, inclusivity, and teamwork. This role is part of the Assay Development team, focusing on developing and optimizing robust multiomics molecular diagnostic assays for in vitro diagnostic (IVD) applications. The position reports to the Director leading the analytical validation program and involves designing, executing, and documenting design verification studies. Collaboration with quality and regulatory functions is key to ensure compliance with design control and risk management requirements. The role requires a strong foundation in Next-Generation Sequencing (NGS) and liquid biopsies, working within a Design Control framework. This is a lab-based position that requires onsite presence when needed for laboratory work, expected to be onsite 5 days a week when needed.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree